231 related articles for article (PubMed ID: 34128238)
21. Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.
Carney BL; Hadland SE; Bagley SM
Pediatr Rev; 2018 Jan; 39(1):43-45. PubMed ID: 29292291
[No Abstract] [Full Text] [Related]
22. The relationship between dissociative symptoms and the medications used in the treatment of opioid use disorder.
Gainer DM; Crawford TN; Fischer KB; Wright MD
J Subst Abuse Treat; 2021 Feb; 121():108195. PubMed ID: 33357605
[TBL] [Abstract][Full Text] [Related]
23. Clinical treatment of opioid addiction and dependence.
Ling W; Rawson RA; Compton M
Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
[No Abstract] [Full Text] [Related]
24. Medication Treatment of Opioid Use Disorder.
Bell J; Strang J
Biol Psychiatry; 2020 Jan; 87(1):82-88. PubMed ID: 31420089
[TBL] [Abstract][Full Text] [Related]
25. Understanding and countering opioid-induced respiratory depression.
Bateman JT; Saunders SE; Levitt ES
Br J Pharmacol; 2023 Apr; 180(7):813-828. PubMed ID: 34089181
[TBL] [Abstract][Full Text] [Related]
26. Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
Zhang P; Tossone K; Ashmead R; Bickert T; Bailey E; Doogan NJ; Mack A; Schmidt S; Bonny AE
J Subst Abuse Treat; 2022 May; 136():108686. PubMed ID: 34953637
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and current clinical practices of opioid treatment programs in the United States.
Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
[TBL] [Abstract][Full Text] [Related]
28. Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
Peterkin A; Laks J; Weinstein ZM
Med Clin North Am; 2022 Jan; 106(1):61-80. PubMed ID: 34823735
[TBL] [Abstract][Full Text] [Related]
29. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
Carswell N; Angermaier G; Castaneda C; Delgado F
Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
[TBL] [Abstract][Full Text] [Related]
30. Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States.
Hochheimer M; Unick GJ
Addict Behav; 2022 Jan; 124():107113. PubMed ID: 34543869
[TBL] [Abstract][Full Text] [Related]
31. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
[No Abstract] [Full Text] [Related]
32. Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.
Bonhomme J; Shim RS; Gooden R; Tyus D; Rust G
J Natl Med Assoc; 2012; 104(7-8):342-50. PubMed ID: 23092049
[TBL] [Abstract][Full Text] [Related]
33. Multimodal assessment of sleep in men and women during treatment for opioid use disorder.
Finan PH; Mun CJ; Epstein DH; Kowalczyk WJ; Phillips KA; Agage D; Smith MT; Preston KL
Drug Alcohol Depend; 2020 Feb; 207():107698. PubMed ID: 31816489
[TBL] [Abstract][Full Text] [Related]
34. The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders.
Alvarez-Perez B; Poras H; Maldonado R
Br J Pharmacol; 2023 Apr; 180(7):879-893. PubMed ID: 34378790
[TBL] [Abstract][Full Text] [Related]
35. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
36. Long-term course of opioid addiction.
Hser YI; Evans E; Grella C; Ling W; Anglin D
Harv Rev Psychiatry; 2015; 23(2):76-89. PubMed ID: 25747921
[TBL] [Abstract][Full Text] [Related]
37. Medication-Assisted Treatment for Opioid-Use Disorder.
Oesterle TS; Thusius NJ; Rummans TA; Gold MS
Mayo Clin Proc; 2019 Oct; 94(10):2072-2086. PubMed ID: 31543255
[TBL] [Abstract][Full Text] [Related]
38. News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic.
Kennedy-Hendricks A; Levin J; Stone E; McGinty EE; Gollust SE; Barry CL
Health Aff (Millwood); 2019 Apr; 38(4):643-651. PubMed ID: 30933576
[TBL] [Abstract][Full Text] [Related]
39. Behavioral pharmacology of buprenorphine.
Mello NK; Mendelson JH
Drug Alcohol Depend; 1985 Feb; 14(3-4):283-303. PubMed ID: 3888577
[TBL] [Abstract][Full Text] [Related]
40. An overview of buprenorphine prescribing for the advanced practice psychiatric nurse.
Kameg B; Fradkin D; Lepore M
Perspect Psychiatr Care; 2022 Oct; 58(4):2059-2063. PubMed ID: 35092616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
